X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Prism Medico and Pharmacy Ltd.
BSE CODE: 512217   |   NSE CODE: NA   |   ISIN CODE : INE730E01016   |   14-May-2024 Hrs IST
BSE NSE
Rs. 22.32
-0.53 ( -2.32% )
 
Prev Close ( Rs.)
22.85
Open ( Rs.)
23.00
 
High ( Rs.)
23.49
Low ( Rs.)
21.25
 
Volume
21477
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)-0.13  -0.61  -0.21  -0.08  0.61  
   CEPS(Rs)-0.12  -0.60  -0.19  -0.05  0.65  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)25.00  20.71  21.32  21.53  21.69  
   Tax Rate(%)25.31  25.86  25.80  26.22  -25.99  
Margin Ratios          
   Core EBITDA Margin(%)-7.64  -5.80  -0.97  -0.19  0.28  
   EBIT Margin(%)-8.03  -5.90  -1.04  -0.25  0.81  
   Pre Tax Margin(%)-8.05  -5.91  -1.05  -0.25  0.81  
   PAT Margin (%)-6.01  -4.38  -0.78  -0.19  1.02  
   Cash Profit Margin (%)-5.50  -4.28  -0.70  -0.12  1.09  
Performance Ratios          
   ROA(%)-0.55  -2.18  -0.60  -0.26  2.47  
   ROE(%)-0.55  -2.90  -1.00  -0.38  2.85  
   ROCE(%)-0.74  -3.91  -1.35  -0.52  2.26  
   Asset Turnover(x)0.09  0.50  0.78  1.40  2.43  
   Sales/Fixed Asset(x)30.16  63.64  76.22  122.27  165.11  
   Working Capital/Sales(x)0.09  0.69  1.54  2.44  11.83  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.03  0.02  0.01  0.01  0.01  
   Receivable days1384.89  397.56  346.74  149.95  37.78  
   Inventory Days1945.06  251.09  53.28  6.85  9.28  
   Payable days0.00  178.61  184.95  82.41  18.50  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  60.73  
   PCE(x)-248.64  -12.79  -60.06  -231.30  56.63  
   Price/Book(x)1.14  0.37  0.55  0.58  1.71  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)13.59  0.54  0.42  0.28  0.61  
   EV/Core EBITDA(x)-180.98  -9.32  -42.94  -148.01  69.71  
   EV/EBIT(x)-169.27  -9.16  -39.89  -109.58  76.05  
   EV/CE(x)1.14  0.37  0.32  0.34  1.31  
   M Cap / Sales13.66  0.55  0.42  0.28  0.62  
Growth Ratio          
   Net Sales Growth(%)-84.95  -49.63  -37.66  -25.93  73.23  
   Core EBITDA Growth(%)80.52  -201.30  -223.51  -115.70  250.12  
   EBIT Growth(%)79.54  -184.90  -157.80  -123.13  526.61  
   PAT Growth(%)79.34  -184.50  -158.70  -113.60  2053.23  
   EPS Growth(%)79.34  -184.52  -158.68  -113.60  2053.23  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.00  0.00  0.00  
   Current Ratio(x)65.34  708.22  2.26  2.29  1.80  
   Quick Ratio(x)36.12  319.61  1.70  2.29  1.55  
   Interest Cover(x)-313.44  -1083.14  -709.78  -272.12  1296.17  
   Total Debt/Mcap(x)0.00  0.00  0.00  0.00  0.00